Jackson Grant Investment Advisers’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$142K Buy
1,639
+2
+0.1% +$192 0.05% 141
2025
Q4
$157K Buy
1,637
+3
+0.2% +$291 0.05% 131
2025
Q3
$156K Buy
1,634
+76
+5% +$6.99K 0.05% 132
2025
Q2
$136K Buy
1,558
+110
+8% +$9.33K 0.05% 131
2025
Q1
$130K Buy
1,448
+3
+0.2% +$268 0.05% 131
2024
Q4
$115K Buy
1,445
+3
+0.2% +$260 0.04% 135
2024
Q3
$130K Buy
1,442
+3
+0.2% +$252 0.05% 134
2024
Q2
$113K Sell
1,439
-310
-18% -$25.4K 0.05% 137
2024
Q1
$152K Buy
1,749
+5
+0.3% +$427 0.06% 119
2023
Q4
$144K Sell
1,744
-510
-23% -$38.9K 0.06% 120
2023
Q3
$177K Buy
2,254
+5
+0.2% +$419 0.09% 101
2023
Q2
$198K Sell
2,249
-89
-4% -$7.66K 0.09% 101
2023
Q1
$189K Buy
2,338
+5
+0.2% +$408 0.09% 104
2022
Q4
$181K Sell
2,333
-500
-18% -$40.5K 0.09% 102
2022
Q3
$229K Sell
2,833
-767
-21% -$68.9K 0.12% 83
2022
Q2
$323K Buy
3,600
+65
+2% +$6.59K 0.16% 75
2022
Q1
$392K Buy
3,535
+3
+0.1% +$317 0.16% 73
2021
Q4
$365K Sell
3,532
-665
-16% -$77K 0.19% 64
2021
Q3
$526K Buy
4,197
+6
+0.1% +$777 0.23% 56
2021
Q2
$520K Buy
4,191
+35
+0.8% +$4.39K 0.23% 58
2021
Q1
$491K Buy
4,156
+379
+10% +$44.4K 0.23% 60
2020
Q4
$442K Buy
3,777
+9
+0.2% +$991 0.23% 56
2020
Q3
$392K Buy
3,768
+10
+0.3% +$1K 0.24% 56
2020
Q2
$345K Buy
3,758
+9
+0.2% +$863 0.22% 59
2020
Q1
$338K Buy
3,749
+7
+0.2% +$745 0.25% 56
2019
Q4
$425K Buy
3,742
+8
+0.2% +$878 0.23% 57
2019
Q3
$406K Buy
3,734
+9
+0.2% +$939 0.23% 56
2019
Q2
$363K Buy
3,725
+9
+0.2% +$822 0.21% 59
2019
Q1
$338K Sell
3,716
-36
-1% -$3.22K 0.2% 57
2018
Q4
$341K Buy
3,752
+171
+5% +$16K 0.24% 55
2018
Q3
$352K Buy
3,581
+12
+0.3% +$1.11K 0.22% 57
2018
Q2
$306K Buy
3,569
+13
+0.4% +$1.09K 0.21% 60
2018
Q1
$285K Buy
3,556
+12
+0.3% +$990 0.2% 63
2017
Q4
$286K Buy
3,544
+197
+6% +$15.8K 0.19% 64
2017
Q3
$260K Buy
3,347
+518
+18% +$43K 0.19% 65
2017
Q2
$251K Sell
2,829
-91
-3% -$7.67K 0.19% 61
2017
Q1
$235K Buy
2,920
+9
+0.3% +$703 0.19% 60
2016
Q4
$207K Sell
2,911
-925
-24% -$72.7K 0.18% 62
2016
Q3
$331K Buy
3,836
+12
+0.3% +$1.05K 0.27% 43
2016
Q2
$332K Buy
3,824
+107
+3% +$8.65K 0.29% 39
2016
Q1
$279K Sell
3,717
-1,120
-23% -$84.4K 0.25% 46
2015
Q4
$372K Buy
+4,837
New +$364K 0.35% 44

Other funds holding MDT

Jackson Grant Investment Advisers's MDT Position: Q1 2026 in Review

Jackson Grant Investment Advisers increased its Medtronic (MDT) stake by 0.12% in Q1 2026, buying an estimated $192 and bringing the position to 1,639 shares worth $142K. The position accounts for 0.05% of the portfolio, ranked #141.

Jackson Grant Investment Advisers first reported a position in MDT in Q4 2015 and has held it in 42 quarters since. The position peaked at $526K in Q3 2021. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Jackson Grant Investment Advisers held 1,639 shares of Medtronic worth $142K as of Q1 2026.
  • Jackson Grant Investment Advisers bought 2 Medtronic shares in Q1 2026, an estimated $192.
  • Medtronic made up 0.05% of Jackson Grant Investment Advisers's portfolio in Q1 2026, its #141 holding.
  • Jackson Grant Investment Advisers first reported a position in Medtronic in Q4 2015 and has held it in 42 quarters since.
  • Jackson Grant Investment Advisers's Medtronic position peaked at $526K in Q3 2021.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q1 2026, filed 8 May 2026.